How COVID-19 is Changing Biologic Workspaces

April 1, 2021 by Alexa Hornbeck
How COVID-19 is Changing Biologic Workspaces

SAN DIEGO – The past four days, hundreds of keynote speakers in academia, biotech, and pharma virtually gathered for the Festival of Biologics.  

Unlike other years, many of the top-producers in the biopharma and life sciences industries discussed how work practices have changed as a result of the COVID-19 crisis.  

Chris McPherson, a senior scientist at Samsung Biologics, described how in only three months his company was able to manufacture and deliver drugs in light of what he called the “black swan,” or unpredictable event.  

McPherson explained that a typical technology transfer timeline takes 12 months, starting from the project kick off, to engineering run, to the clinical run. But his team was able to expedite that timeline to three months.

Using four case studies, McPherson illustrated that when his lab experienced supply issues from a shortage of raw material availability, that they were able to resolve the issue by, “leveraging Samsung’s biologics plants at one time.” 

Gimbal-mounted, high-definition cameras, allowed for things such as virtual meetings, data sharing, and client access for audits and tours inside the lab. The cameras allowed McPherson and his team to zoom in and out of various pieces of equipment to show what was happening on the ground floor during a time his clients could not physically be there.  

Mcpherson said these improvements in manufacturing and delivering drugs won’t just happen because of COVID-19 but are sustainable long-term.  

The year 2020 also galvanized efforts to increase diversity, equity, and inclusion in the workplace, as biopharma and life science CEOs looked to providing more roles for women and other underrepresented populations.  

“A lot of companies have gender balance at about 50/50, but when you look at senior roles you see less women represented, and the same is true of diversity as well,” stated Rebecca Sendak, the head of Global Large Molecules Research Platform at Sanofi.  

“2020 was a powerful year for our company,” explained Kristen Hege, senior vice president in Early Clinical Development in Hematology and Oncology at Bristol-Myers Squibb.   

Hege explained that her CEO Giovanni Caforio made a public commitment of $3 million over the next five years to expand health equity and diversity and inclusion efforts, like increasing supplier diversity with Black, African American owned businesses.  

“We trained 250 new racially and ethnically diverse clinical investigators, understanding that to enroll more diverse patients in clinical trials we need more investigators that connect at a personal level with those patients,” stated Hege.  

Other female panelists discussed changes in workspaces such as having “equity audits,” to interrogate policies and practices which don’t align with equity and inclusivity values.  

“I think the George Floyd murder woke a lot of people up and having that graphically captured struck a chord. When those events unfolded, there were people who wanted to talk about it. We scheduled events and brought in guest speakers to talk about things that were once taboo to talk about. We saw a shift from 2020 in that regard,” stated Sendak.  

A+
a-
  • biologic workplaces
  • Chris McPherson
  • Festival of Biologics
  • Samsung Biologics
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top